Staar Surgical (STAA) Net Income towards Common Stockholders (2010 - 2026)

Staar Surgical's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at $5.2 million for Q2 2026.

• Quarterly Net Income towards Common Stockholders rose 109.6% year-over-year to $5.2 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$21.0 million (up 79.66% YoY) and the FY2026 annual result came in at -$80.4 million, down 53.15% from the prior year.
• Net Income towards Common Stockholders was $5.2 million for Q2 2026 at Staar Surgical, up from -$18.3 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $59.4 million in Q4 2023 and bottomed at -$66.5 million in Q4 2024.
• A 5-year average of -$4.7 million and a median of $5.2 million in 2026 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders jumped 201.78% — and 2025, when it sank 1523.57%.
• Staar Surgical's Net Income towards Common Stockholders stood at -$58.4 million in 2022, then soared by 201.78% to $59.4 million in 2023, then tumbled by 212.0% to -$66.5 million in 2024, then soared by 113.35% to $8.9 million in 2025, then plunged by 41.4% to $5.2 million in 2026.
• Business Quant data shows STAA's Net Income towards Common Stockholders at $5.2 million in Q2 2026, -$18.3 million in Q1 2026, and $8.9 million in Q3 2025.